Arrowhead Research VP of Intellectual Property to Speak at NanoBusiness 2006.PASADENA, Calif. -- Arrowhead Research Corporation (Nasdaq:ARWR) announced that its vice president of intellectual property, John C. Miller, will participate in the Fifth Annual NanoBusiness 2006 conference in the Converging Technologies Bar Association Tutorial to be held on Thursday, May 18, from 2:30-4 p.m. at the New York Marriott Marquis New York Marriott Marquis Times Square at 1531-1549 Broadway opened in 1985 and was designed by architect John Portman. It is located in the heart of Times Square at Broadway and 45th Street. . Beyond serving as vice president, intellectual property for Arrowhead Research Corporation, Miller is founder of NanoPolaris, Inc., a wholly owned subsidiary Wholly Owned Subsidiary A subsidiary whose parent company owns 100% of its common stock. Notes: In other words, the parent company owns the company outright and there are no minority owners. of Arrowhead Research Corporation, which offers a customized nanotube A carbon molecule that resembles a cylinder made out of chicken wire one to two nanometers in diameter by any number of millimeters in length. Accidentally discovered by a Japanese researcher at NEC in 1990 while making Buckyballs, they have potential use in many applications. patent portfolio licensing program. Miller is also managing editor of Nanotechnology Law & Business, a peer-reviewed, quarterly journal. He has published various articles on nanotechnology legal and policy issues and co-authored "The Handbook of Nanotechnology Business, Policy, and Intellectual Property Law" (John Wiley John Wiley may refer to:
About Arrowhead Research Corporation Arrowhead Research Corporation (www.arrowheadresearch.com) is a diversified nanotechnology company structured to commercialize products expected to have revolutionary impacts on a variety of industries, including materials, electronics, life sciences, and energy. There are three strategic components to Arrowhead's business model: --Outsourced R&D Program: Arrowhead identifies patented or patent-pending technologies at universities or government labs and funds additional development of those technologies in exchange for exclusive rights to commercialize the resulting prototypes. Leveraging the resources and infrastructure of these institutions provides Arrowhead with a cost-effective development pipeline. Currently, Arrowhead is supporting efforts in drug discovery tools, stem cell stem cell In living organisms, an undifferentiated cell that can produce other cells that eventually make up specialized tissues and organs. There are two major types of stem cells, embryonic and adult. technology, and nanoelectronics at the California Institute of Technology California Institute of Technology, at Pasadena, Calif.; originally for men, became coeducational in 1970; founded 1891 as Throop Polytechnic Institute; called Throop College of Technology, 1913–20. , Stanford University Stanford University, at Stanford, Calif.; coeducational; chartered 1885, opened 1891 as Leland Stanford Junior Univ. (still the legal name). The original campus was designed by Frederick Law Olmsted. David Starr Jordan was its first president. , and Duke University, respectively. --Commercialization Program: After prototypes have been sufficiently developed in the laboratories, Arrowhead forms or acquires majority-owned subsidiaries to commercialize the technology and provides the subsidiaries with strategic, managerial, and operational support. By doing so, each research team is able to maintain focus on its specific technology and each management team can focus on specific markets, increasing the likelihood of successful technological development and commercialization. At present, Arrowhead owns majority interest in subsidiaries commercializing diverse technologies, including anti-cancer drugs, RNAi therapeutics, compound semiconductor materials Semiconductor materials are insulators at absolute zero temperature that conduct electricity in a limited way at room temperature (see also Semiconductor). The defining property of a semiconductor material is that it can be doped with impurities that alter its electronic properties , and nanotube technology. --The Patent Toolbox: Arrowhead has acquired or exclusively licensed patents and patent applications covering a broad range of nanotechnology. The Company actively adds to its intellectual property portfolio. About NanoPolaris, Inc. NanoPolaris is a wholly owned subsidiary of Arrowhead Research Corporation. With exclusively licensed commercial rights to nanotube technology developed at some of the world's most respected research universities, the NanoPolaris IP portfolio includes patents and patent applications claiming nanotube compositions of matter and general manufacturing techniques such as chemical vapor deposition Vapor deposition Production of a film of material often on a heated surface and in a vacuum. Vapor deposition technology is used in a large variety of applications. synthesis, plasma chemical vapor deposition synthesis, purification, solubilization, separation of certain types of tubes, coatings, functionalization, and manipulation. NanoPolaris is developing a customized portfolio license program for customers in different industries who will utilize nanotube technology with their products. Safe Harbor Safe Harbor 1. A legal provision to reduce or eliminate liability as long as good faith is demonstrated. 2. A form of shark repellent implemented by a target company acquiring a business that is so poorly regulated that the target itself is less attractive. Statement under the Private Securities Litigation Reform Act The Private Securities Litigation Reform Act of 1995 (PSLRA) implemented several significant substantive changes affecting certain cases brought under the federal securities laws, including changes related to pleading, discovery, liability, class representation and awards fees and of 1995: This news release contains forward-looking statements within the meaning of the "safe harbor" provisions of the Private Securities Litigation Reform Act of 1995. These statements are based upon our current expectations and speak only as of the date hereof. Our actual results may differ materially and adversely from those expressed in any forward-looking statements as a result of various factors and uncertainties, including the recent economic slowdown affecting technology companies; the future success of our scientific studies; our ability to successfully develop products; rapid technological change in our markets; changes in demand for our future products; legislative, regulatory, and competitive developments; and general economic conditions. Our Annual Report on Form 10-K Form 10-K A report required by the SEC from exchange-listed companies that provides for annual disclosure of certain financial information. Form 10-K See 10-K. and 10-K/A, recent and forthcoming Quarterly Reports on Form 10-Q Form 10-Q See 10-Q. and 10-Q/A, recent Current Reports on Forms 8-K and 8-K/A, our Registration Statements on Form S-3, and other SEC filings discuss some of the important risk factors that may affect our business, results of operations, and financial condition. We undertake no obligation to revise or update publicly any forward-looking statements for any reason. |
|
||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion